GL1X · GenesisL1 explorer

MolNFT v1 · #97393 · protein

Human dck C4S-S74E mutant in complex with udp and the di-39 inhibitor

4KCG · Deoxycytidine kinase: “Human dck C4S-S74E mutant in complex with udp and the di-39 inhibitor”. X-ray diffraction, 2 ligands (1QC, UDP), 2 pockets (best druggability 0.74). MolNFT v1 #97393 on GenesisL1: 3D structure, binding sites…

PDB
4KCG
Type
protein
Length
460 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Deoxycytidine kinase
EC
2.7.1.74
UniProt
P27707
Ligands
1QC, UDP
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 57% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADeoxycytidine kinase (EC 2.7.1.74)protein23059% helix, 11% strandP27707
BDeoxycytidine kinase (EC 2.7.1.74)protein23054% helix, 11% strandP27707

Ligands and binding sites

  • 1QC · N-{2-[5-(4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-1,3-thiazol-2-yl)-2-methoxyphenoxy]ethyl}methanesulfonamide · ligand · 2 copies · chains A, B
  • UDP · Uridine-5'-diphosphate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13520.740.85431QC, UDP
23610.720.84431QC, UDP

Interfaces

1 interface between chains.

  • A–B · 1298 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4KCG · Human dCK C4S-S74E mutant in complex with UDP and the DI-39 inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P27707 · AlphaFold monomer V2.0 prediction for deoxycytidine kinase (P27707) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.